Litcius/Paper detail

Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3

Prerna Arora, Lu Zhang, Cheila Rocha, Anzhalika Sidarovich, Amy Kempf, Sebastian Schulz, Anne Cossmann, Bernhard Manger, Eva Baier, Björn Tampe, Onnen Moerer, Steffen Dickel, Alexandra Dopfer‐Jablonka, Hans‐Martin Jäck, Georg M. N. Behrens, Martin Sebastian Winkler, Stefan Pöhlmann, Markus Hoffmann

2022The Lancet Infectious Diseases109 citationsDOIOpen Access PDF

Topics & Concepts

NeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Evasion (ethics)Virology2019-20 coronavirus outbreakBiologyMedicineGeneticsVirusOutbreakInfectious disease (medical specialty)PathologyDiseaseImmune systemSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies
Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3 | Litcius